TABITHA RAJASAARI: Open Payments
NPI 1467124321 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,009 in 102 payments from 32 companies in 2025. Trend: 2023 $436 · 2024 $1,139 · 2025 $2,009
Food & beverage: $2,009
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $334 |
| Teva Pharmaceuticals USA, Inc. | 10 | $193 |
| Neurocrine BioSciences, Inc. | 14 | $191 |
| Tanabe Pharma America, Inc. | 5 | $105 |
| Lundbeck LLC | 4 | $99 |
| TG Therapeutics, Inc. | 3 | $95 |
| JAZZ PHARMACEUTICALS INC. | 3 | $87 |
| Alnylam Pharmaceuticals Inc. | 3 | $79 |
| Grifols USA, LLC | 3 | $72 |
| Axsome Therapeutics, Inc. | 2 | $66 |
Products named: QULIPTA, AUSTEDO XR, INGREZZA, Radicava, VYEPTI, BRIUMVI, EPIDIOLEX, AMVUTTRA.
Industry payments across TN — which companies pay providers there.
